392 related articles for article (PubMed ID: 18088505)
21. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
22. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
[TBL] [Abstract][Full Text] [Related]
23. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2).
Chu XY; Strauss JR; Mariano MA; Li J; Newton DJ; Cai X; Wang RW; Yabut J; Hartley DP; Evans DC; Evers R
J Pharmacol Exp Ther; 2006 May; 317(2):579-89. PubMed ID: 16421286
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms involved in spironolactone-induced choleresis in the rat. Role of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Sánchez-Pozzi EJ; Crocenzi FA; Pellegrino JM; Ochoa JE; Vore M; Mottino AD; Catania VA
Biochem Pharmacol; 2005 Feb; 69(3):531-9. PubMed ID: 15652244
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver.
Higaki K; Ishii M; Esumi H; Kanayama M; Ogawara KI; Kimura T
Xenobiotica; 2003 Nov; 33(11):1097-108. PubMed ID: 14660174
[TBL] [Abstract][Full Text] [Related]
27. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
28. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver.
Platzer P; Thalhammer T; Reznicek G; Hamilton G; Zhang R; Jäger W
Int J Oncol; 2001 Dec; 19(6):1287-93. PubMed ID: 11713602
[TBL] [Abstract][Full Text] [Related]
29. Altered hepatobiliary disposition of 5 (and 6)-carboxy-2',7'-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice.
Nezasa K; Tian X; Zamek-Gliszczynski MJ; Patel NJ; Raub TJ; Brouwer KL
Drug Metab Dispos; 2006 Apr; 34(4):718-23. PubMed ID: 16434545
[TBL] [Abstract][Full Text] [Related]
30. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
Lagas JS; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Mol Pharmacol; 2010 Apr; 77(4):687-94. PubMed ID: 20086033
[TBL] [Abstract][Full Text] [Related]
31. OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human.
Sun P; Wang C; Liu Q; Meng Q; Zhang A; Huo X; Sun H; Liu K
Pharmacol Rep; 2014 Apr; 66(2):311-9. PubMed ID: 24911086
[TBL] [Abstract][Full Text] [Related]
32. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
Chen C; Hennig GE; Manautou JE
Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo hepatic transport of the magnetic resonance imaging contrast agent B22956/1: role of MRP proteins.
Lorusso V; Pascolo L; Fernetti C; Visigalli M; Anelli P; Tiribelli C
Biochem Biophys Res Commun; 2002 Apr; 293(1):100-5. PubMed ID: 12054569
[TBL] [Abstract][Full Text] [Related]
34. Effect of DPC 333 [(2R)-2-{(3R)-3-amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide], a human tumor necrosis factor alpha-converting enzyme inhibitor, on the disposition of methotrexate: a transporter-based drug-drug interaction case study.
Luo G; Garner CE; Xiong H; Hu H; Richards LE; Brouwer KL; Duan J; Decicco CP; Maduskuie T; Shen H; Lee FW; Gan LS
Drug Metab Dispos; 2007 Jun; 35(6):835-40. PubMed ID: 17332143
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
36. Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides.
Lischka K; Starke D; Failing K; Herling A; Kramer W; Petzinger E
Biochem Pharmacol; 2003 Aug; 66(4):565-77. PubMed ID: 12906921
[TBL] [Abstract][Full Text] [Related]
37. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
[TBL] [Abstract][Full Text] [Related]
38. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat.
Jäger W; Winter O; Halper B; Salamon A; Sartori M; Gajdzik L; Hamilton G; Theyer G; Graf J; Thalhammer T
Hepatology; 1997 Dec; 26(6):1467-76. PubMed ID: 9397986
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides.
van de Wetering K; Zelcer N; Kuil A; Feddema W; Hillebrand M; Vlaming ML; Schinkel AH; Beijnen JH; Borst P
Mol Pharmacol; 2007 Aug; 72(2):387-94. PubMed ID: 17485564
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
